Scientists have discovered a new mechanism of inhibiting a critical enzyme of the SARS-CoV-2 virus, demonstrating the on-target engagement of novel selenium based compounds. An international team of researchers led by the University of Liverpool has shown that a Selenium-based drug molecule called ebselen and several derivative compounds can halt SARS-CoV-2 replication by targeting its main protease...
